Getting your player ready...
CHICAGO — Millions of people who are struggling with the tough-to-use blood thinner warfarin, sold as Coumadin and other brands, may soon have another alternative.
An experimental Johnson & Johnson drug prevented strokes in people with a common heart-rhythm problem as well as warfarin did and without an increase in bleeding or other side effects, a major study found. It was reported Monday at an American Heart Association conference in Chicago. The Associated Press
